跳转至内容
Merck
所有图片(1)

文件

14380C

SAFC

EX-CELL® CD昆虫细胞培养基

Chemically defined, sterile-filtered, suitable (for insect cell culture)

制药生产

登录查看公司和协议定价
所有图片(1)

About This Item

分類程式碼代碼:
12352207

品質等級

500

無菌

sterile-filtered

產品線

EX-CELL®

形狀

liquid

技術

cell culture | insect: suitable

成分

NaHCO3: no
L-glutamine: yes

運輸包裝

ambient

儲存溫度

2-8°C

相关类别

一般說明

EX-CELL® CD昆虫细胞培养基可作为草地夜蛾(Spodoptera frugiperda, Sf)细胞（例如Sf21和Sf9细胞）的扩增和生产培养基，也适合Tni、C636和S2细胞。该培养基优化用于无弹状病毒的Sf-RVN™昆虫细胞株(Sf9)的优异生长和生产，两者共同组成Sf-RVN™平台。培养基配方化学成分明确、不含动物成分，含有L-谷氨酰胺。

法律資訊

EX-CELL is a registered trademark of Merck KGaA, Darmstadt, Germany
Sf-RVN is a trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類（WGK）

WGK 1

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 1

1 of 1

EX-CELL® Advanced CHO Fed-batch培养基 liquid

SAFC

14366C

EX-CELL® Advanced CHO Fed-batch培养基

商品

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Cell and Gene Therapy Manufacturing: Upstream Processing for AAV and Lentivirus Platforms

Minimize the complexities of cell and gene therapy production. Switch to upstream viral vector platforms to enhance scalability and simplify GMP manufacturing.

查看所有结果

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门